Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 11/20 | 1.00 |
| ▸ | GRIN2B | Q13224 | 11/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.53 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.53 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.53 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.53 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5237195 | 0.91 | GRIN1 (0.84) | GRIN1GRIN2BGAATHRBGRIN2D | |
| SCHEMBL8313704 | 0.89 | GRIN1 (1.00) | GRIN1GRIN2B | |
| SCHEMBL8318042 | 0.89 | GRIN1 (1.00) | GRIN1GRIN2B | |
| SCHEMBL8320273 | 0.89 | GRIN1 (1.00) | GRIN1GRIN2B | |
| SCHEMBL8312848 | 0.86 | GRIN1 (0.80) | GRIN1GRIN2B | |
| SCHEMBL1388535 | 0.86 | GRIN2B (1.00) | GRIN1GRIN2BTHRBGRIN2AGRIN2C | |
| SCHEMBL8318192 | 0.85 | GRIN1 (1.00) | GRIN1GRIN2BGAA | |
| SCHEMBL8319076 | 0.84 | GRIN1 (1.00) | GRIN1GRIN2BGAA | |
| SCHEMBL8313716 | 0.81 | GRIN1 (0.67) | GRIN1GRIN2BGAAPKMTSHR | |
| SCHEMBL5269544 | 0.81 | GRIN1 (0.84) | GRIN1GRIN2BTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004048364-A1 | 2-[(4-BENZYL)-1-PIPERIDINYL)METHYL]BENZIMIDAZOLE-5-OL DERIVATIVES AS NR2B RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2004-06-10 | — | — | WO | disclosed |